These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18902136)

  • 21. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
    Mavrogordato A; Lever AM
    J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aralen and paludrine antimalarial prophylaxis in the rural regions].
    HIMPE NE; PIERQUIN L
    Ann Soc Belg Med Trop (1920); 1950 Jun; 30(2):217-46. PubMed ID: 15433059
    [No Abstract]   [Full Text] [Related]  

  • 23. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on synthetic antimalarial drugs; the blood concentrations and physiological distribution of some homologues of paludrine in relation to their antimalarial activities.
    SPINKS A
    Ann Trop Med Parasitol; 1948 Sep; 42(2):190-7. PubMed ID: 18891445
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical pharmacology of atovaquone and proguanil hydrochloride.
    Beerahee M
    J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
    Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M
    JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentaquine (SN-13,276) a new antimalarial effective in reducing the relapse rate of vivax malaria.
    PULLMAN TN; ALVING AS
    Proc Annu Meet Cent Soc Clin Res U S; 1946 Nov 1-2; 19():83. PubMed ID: 20343588
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmacology of paludrine and some other new antimalarials.
    SPINKS A; TOTTEY MM; MAEGRAITH BG
    Biochem J; 1946; 40(1):i. PubMed ID: 21027565
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on synthetic antimalarial drugs; a preliminary investigation of the therapeutic action of 3349 on acute attacks of benign tertian malaria.
    ADAMS AR; SANDERSON G
    Ann Trop Med Parasitol; 1945 Dec; 39():165-8. PubMed ID: 21013245
    [No Abstract]   [Full Text] [Related]  

  • 30. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
    Lell B; Luckner D; Ndjavé M; Scott T; Kremsner PG
    Lancet; 1998 Mar; 351(9104):709-13. PubMed ID: 9504515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metachloridine-substituted aryl biguanides as possible antimalarial compounds.
    BAMI HL; IYER BH; GUHA PC
    Nature; 1948 Jul; 162(4108):146. PubMed ID: 18939062
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on synthetic antimalarial drugs; a comparison of the therapeutic actions of 3349 and of mepacrine hydrochloride on acute attacks of benign tertian malaria.
    ADAMS AR; SANDERSON G
    Ann Trop Med Parasitol; 1945 Dec; 39():180. PubMed ID: 21013248
    [No Abstract]   [Full Text] [Related]  

  • 33. Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations.
    Kaneko A; Bergqvist Y; Taleo G; Kobayakawa T; Ishizaki T; Björkman A
    Pharmacogenetics; 1999 Jun; 9(3):317-26. PubMed ID: 10471063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A shorter course for anti-relapse therapy against vivax malaria.
    Rosenthal PJ
    Lancet; 2019 Sep; 394(10202):898-900. PubMed ID: 31327565
    [No Abstract]   [Full Text] [Related]  

  • 37. Relapsing vivax malaria after 6 months of daily atovaquone/proguanil in Afghanistan: the case for expanded use of primaquine as a causal prophylactic.
    Maguire JD; Llewellyn DM
    J Travel Med; 2007; 14(6):411-4. PubMed ID: 17995538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area.
    Pang LW; Limsomwong N; Singharaj P; Canfield CJ
    Bull World Health Organ; 1989; 67(1):51-8. PubMed ID: 2706727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paludrine, a new anti-malarial drug.
    CHOUDHURY M
    Antiseptic; 1947 Sep; 44(9):606-8. PubMed ID: 18897458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.